Herpes simplex virus (HSV) is spread by direct contact ‘shedding’ from one host to another. Two viral subtypes exist: type I is associated mainly with facial lesions although the fingers and genitals may be affected. Type II is associated almost entirely with genital infections.
Primary herpes simplex (type I) infection usually occurs in or around the mouth, with variable involvement of the face.
Recurrent eruption characterized by grouped vesicles on an erythematous base that progress to erosions; often secondarily infected with staphylococci or streptococci. Infections frequently involve mucocutaneous surfaces around the oral cavity, genitals, or anus.
Treatment Herpes Simplex
Antiviral treatment: Seven days after intense exposure, prophylaxis can be given to high-risk pts who are ineligible for vaccine or for whom the 96-h window after direct contact has passed. This intervention may lessen illness severity.